Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Net Income towards Common Stockholders (2018 - 2026)

Arcturus Therapeutics Holdings filings provide 8 years of Net Income towards Common Stockholders readings, the most recent being -$29.1 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 3.09% to -$29.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$65.8 million, a 18.74% increase, with the full-year FY2025 number at -$65.8 million, up 18.73% from a year prior.
  • Net Income towards Common Stockholders hit -$29.1 million in Q4 2025 for Arcturus Therapeutics Holdings, down from -$13.4 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $118.6 million in Q4 2022 to a low of -$57.7 million in Q1 2021.
  • Median Net Income towards Common Stockholders over the past 5 years was -$24.2 million (2022), compared with a mean of -$18.4 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 509.45% in 2021 and later surged 415.16% in 2022.
  • Arcturus Therapeutics Holdings' Net Income towards Common Stockholders stood at -$37.6 million in 2021, then surged by 415.16% to $118.6 million in 2022, then plummeted by 109.84% to -$11.7 million in 2023, then crashed by 156.89% to -$30.0 million in 2024, then increased by 3.09% to -$29.1 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$29.1 million (Q4 2025), -$13.4 million (Q3 2025), and -$9.2 million (Q2 2025) per Business Quant data.